Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency
RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination
Explore topics from oligonucleotides and high-sensitivity troponin assays to therapeutic antibodies and advances in COVID-19 sample prep
New capsid free antigen overcomes cross-reactivity difficulties, reducing the likelihood of false positives
Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics
Enables researchers to generate more data in less time to support both preclinical and clinical studies
New crowdsourcing project to examine the ‘Translocation of Complex Macromolecules Across the Intestinal Epithelial Barrier’
This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2
With this addition, researchers can more easily screen for small molecule modulators of cGAS
Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others
In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively
